Isolation and molecular characterisation of Achromobacter phage phiAxp-3, an N4-like bacteriophage

Yanyan Ma1, Erna Li2, Zhizhen Qi3

  • 1College of Food Science, Henan Institute of Science and Technology, Xinxiang, 453003, China.

Scientific Reports
|April 21, 2016
PubMed

Insights

A novel bacteriophage, phiAxp-3, was isolated and characterized for its potential to infect Achromobacter xylosoxidans. This research provides insights into bacteriophage therapy against this opportunistic pathogen.

Area of Science:

  • Microbiology
  • Virology
  • Bacteriophage Research

Background:

  • Achromobacter xylosoxidans is an opportunistic pathogen causing nosocomial and community-acquired infections.
  • There is an urgent need for alternative therapies against antibiotic-resistant bacteria.

Purpose of the Study:

  • To isolate and characterize a bacteriophage infecting A. xylosoxidans.
  • To investigate the genomic and biological properties of the isolated phage, named phiAxp-3.
  • To explore the potential of phiAxp-3 as a therapeutic agent.

Main Methods:

  • Isolation of bacteriophage phiAxp-3 from hospital waste.
  • Transmission electron microscopy for morphological characterization.
  • Determination of burst size, latent period, and host range.
  • Whole-genome sequencing and bioinformatic analysis.
  • Proteomic analysis to identify viral proteins.
  • Investigation of the phage receptor on the host cell surface.

Main Results:

  • phiAxp-3 is an N4-like bacteriophage belonging to the Podoviridae family, with an icosahedral head and non-contractile tail.
  • The phage has a burst size of 9000 PFU and a latent period of 80 minutes, with a limited host range infecting 4 out of 35 A. xylosoxidans strains.
  • The 72,825 bp genome contains 80 predicted open reading frames, with no identified virulence or drug resistance genes.
  • Proteomics identified 25 viral proteins, and lipopolysaccharide was identified as the receptor for phage adsorption.
  • Genome comparisons suggest a closer relationship to JWAlpha and JWDelta phages than other N4 viruses.

Conclusions:

  • phiAxp-3 is a novel bacteriophage with potential for targeting A. xylosoxidans infections.
  • Understanding its genomic and biological properties is crucial for developing phage-based therapies.
  • The identification of lipopolysaccharide as the receptor provides a basis for further studies on phage-host interactions.